[ad_1] Abbott Laboratories ABT, -1.06% said that a Food and Drug Administration panel voted in…
Tag:
Product/Service Approvals
-
-
[ad_1] Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer…
-
[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the…
-
STOCK MARKET
Panbela Therapeutics’ stock soars on positive FDA news on child cancer treatment
by userby user[ad_1] Shares of Panbela Therapeutics Inc. skyrocketed again Tuesday, following positive news from the U.S.…
-
[ad_1] Medtronic MDT, +2.27% said the U.S. Food and Drug Administration has approved its PulseSelect…
-
STOCK MARKET
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
by userby user[ad_1] Crispr Therapeutics AG CRSP, -5.33% and Vertex Pharmaceuticals Inc. VRTX, -0.82% on Friday got…
-
STOCK MARKET
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
by userby user[ad_1] Shares of Cabaletta Bio Inc. CABA, Gracell Biotechnologies Inc. GRCL and other smaller biotech…
-
STOCK MARKET
SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors
by userby user[ad_1] SpringWorks Therapeutics Inc. shares SWTX were on track for a record percentage gain on…
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby user[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
-
STOCK MARKET
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
by userby user[ad_1] Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer’s treatment…